Trump's tariffs on Mexico and Canada pose challenges for auto industry, impacting global market.
From CNBC: 2025-02-01 20:48:18
A car carrier trailer waits at the border wall to cross into the US from Mexico. Trump’s 25% tariffs on Canadian, Mexican, and Chinese goods will impact the global auto industry, with Mexico expected to be hardest hit. Automakers face additional costs and uncertainty, potentially passing them on to consumers and reducing demand. Tariffs could cost companies billions and affect GM’s earnings, with significant operations in North America. S&P Global Mobility warns of massive impact on the auto industry. Mexico and Canada plants produce 5.3 million vehicles, with majority destined for the US. Some automakers rely heavily on Mexico production, including Volkswagen, Nissan, and Stellantis. Antonio Filosa of Stellantis prepares for potential decisions impacting their operations. 1. The stock market experienced a significant drop today, with the S&P 500 falling by 3% and the Dow Jones Industrial Average dropping by 800 points. Investors are concerned about rising inflation rates and the potential impact on the economy.
2. The United Nations released a report stating that global temperatures are rising at an alarming rate, with 2021 being one of the hottest years on record. The report highlights the urgent need for countries to take action to reduce carbon emissions and combat climate change.
3. The CDC announced that the Delta variant of COVID-19 is now the dominant strain in the United States, accounting for over 80% of new cases. Health officials are urging unvaccinated individuals to get vaccinated to protect themselves and others from the highly contagious variant.
4. Tesla reported a record-breaking quarter, with $1.1 billion in net income and $11.96 billion in revenue. The electric car company also delivered over 200,000 vehicles in the quarter, surpassing analyst expectations and demonstrating continued growth in the electric vehicle market.
5. The European Union has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15. The decision comes as countries across Europe work to vaccinate younger populations and prevent the spread of the virus among school-aged children.
Read more at CNBC: Trump’s tariffs on Mexico and Canada challenge auto industry